News

Alfasigma S.p.A today announced positive topline results from the OLINGUITO Phase 3 clinical trial (NCT05785611; Eudra CT ...
A Halifax photographer using ChatGPT to transform her images into illustrations is opening up a conversation about the purpose of art in the age of artificial intelligence.